Michael P. Samar
CIK 1775910 · Chief Financial Officer · last filed 2024-06-21
Michael P. Samar is a Chief Financial Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for UBX, was dated Jun 21, 2024. Across all open-market trades the lifetime net is −$9.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.77M
2
8
-$9.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Unity Biotechnology, Inc. (UBX) Delisted | Director | — | $0.20 | — | $0 | 4 | 2024-06-21 |
| ASMB | Chief Financial Officer | 77,228 | $22.96 | $1.77M | -$9.4K | 4 | 2022-07-26 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-21 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-07-26 | ASMB | Sell (S) | −2,020 | -$4.5K | EDGAR |
| 2022-06-27 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-31 | ASMB | Mixed | +23,965 | -$5.0K | EDGAR |
| 2021-07-22 | ASMB | Grant (A) | +10,938 | $0 | EDGAR |
| 2019-10-01 | ASMB | Grant (A) | +2,500 | $0 | EDGAR |